CC BY-NC 4.0 · Arch Plast Surg 2014; 41(05): 466-471
DOI: 10.5999/aps.2014.41.5.466
Original Article

Effect of Recombinant Human Epidermal Growth Factor Impregnated Chitosan Film on Hemostasis and Healing of Blood Vessels

Sangshin Lee
Department of Plastic and Reconstructive Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
,
Inwook Jung
Department of Plastic and Reconstructive Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
,
Seongcheol Yu
Department of Plastic Surgery, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea
,
Joon Pio Hong
Department of Plastic and Reconstructive Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
› Author Affiliations

Background Bleeding can be a problem in wound debridement. In search for an effective hemostatic agent, we experimented with a chitosan film combined with the recombinant human epidermal growth factor (rh-EGF), hypothesizing that it would achieve effective hemostasis and simultaneously enhance arterial healing.

Methods Forty-eight Sprague-Dawley rats were used, and 96 puncture wounds were made. The wounds were divided into the following four groups: treated with sterile gauze, treated with gelatin sponge, treated with chitosan, and treated with chitosan combined with rh-EGF. Immediate hemostasis was evaluated, and arterial healing was observed histologically.

Results Groups B, C, and D showed a significant rate of immediate hemostasis as compared to group A (P<0.05), but there were no significant differences among groups B, C, and D. Histologically, only group D showed good continuity of the vessel wall after 1 week. It was the only group to show smooth muscle cell nuclei of the vessel wall.

Conclusions We observed that chitosan has an effective hemostatic potential and the mix of rh-EGF and chitosan does not interfere with chitosan's hemostatic capabilities. We also identified enhanced healing of vessel walls when rh-EGF was added to chitosan. Further research based on these positive findings is needed to evaluate the potential use of this combination on difficult wounds like chronic diabetic ulcerations.



Publication History

Received: 01 January 2014

Accepted: 08 May 2014

Article published online:
05 May 2022

© 2014. The Korean Society of Plastic and Reconstructive Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonCommercial License, permitting unrestricted noncommercial use, distribution, and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes. (https://creativecommons.org/licenses/by-nc/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Schafer AI. Approach to the patient with bleeding and thrombosis. In: Goldman L, Ausiello DA, Arend W. Cecil medicine. 23rd ed. Philadelphia: Saunders Elsevier; 2008: 1286-1288
  • 2 Sabino L, Andreoni C, Faria EF. et al. Evaluation of renal defect healing, hemostasis, and urinary fistula after laparoscopic partial nephrectomy with oxidized cellulose. J Endourol 2007; 21: 551-556
  • 3 Li Q, Dunn ET, Grandmaison EW. et al. Applications and properties of chitosan. J Bioact Compat Polym 1992; 7: 370-397
  • 4 Gebelein CG, Dunn RL. American Chemical Society Meeting. Progress in biomedical polymers. New York: Plenum Press; 1990
  • 5 Chou TC, Fu E, Wu CJ. et al. Chitosan enhances platelet adhesion and aggregation. Biochem Biophys Res Commun 2003; 302: 480-483
  • 6 Klokkevold PR, Lew DS, Ellis DG. et al. Effect of chitosan on lingual hemostasis in rabbits. J Oral Maxillofac Surg 1991; 49: 858-863
  • 7 Klokkevold PR, Fukayama H, Sung EC. et al. The effect of chitosan (poly-N-acetyl glucosamine) on lingual hemostasis in heparinized rabbits. J Oral Maxillofac Surg 1999; 57: 49-52
  • 8 Santa Maria PL, Redmond SL, Atlas MD. et al. The role of epidermal growth factor in the healing tympanic membrane following perforation in rats. J Mol Histol 2010; 41: 309-314
  • 9 Hom DB, Maisel RH. Angiogenic growth factors: their effects and potential in soft tissue wound healing. Ann Otol Rhinol Laryngol 1992; 101: 349-354
  • 10 Niemi TT, Taxell C, Rosenberg PH. Comparison of the effect of intravenous ketoprofen, ketorolac and diclofenac on platelet function in volunteers. Acta Anaesthesiol Scand 1997; 41: 1353-1358
  • 11 Groenewold MD, Gribnau AJ, Ubbink DT. Topical haemostatic agents for skin wounds: a systematic review. BMC Surg 2011; 11: 15
  • 12 Arbel J, Rozenbaum E, Reges O. et al. USage of chitosan for Femoral (USF) haemostasis after percutaneous procedures: a comparative open label study. EuroIntervention 2011; 6: 1104-1109
  • 13 Burkatovskaya M, Castano AP, Demidova-Rice TN. et al. Effect of chitosan acetate bandage on wound healing in infected and noninfected wounds in mice. Wound Repair Regen 2008; 16: 425-431
  • 14 Burkatovskaya M, Tegos GP, Swietlik E. et al. Use of chitosan bandage to prevent fatal infections developing from highly contaminated wounds in mice. Biomaterials 2006; 27: 4157-4164
  • 15 Hong JP, Kim YW, Lee SK. et al. The effect of continuous release of recombinant human epidermal growth factor (rh-EGF) in chitosan film on full thickness excisional porcine wounds. Ann Plast Surg 2008; 61: 457-462
  • 16 Cho KS, Shin SK, Lee JH. et al. The efficacy of Cutanplast nasal packing after endoscopic sinus surgery: a prospective, randomized, controlled trial. Laryngoscope 2013; 123: 564-568
  • 17 Brown GL, Curtsinger 3rd L, Brightwell JR. et al. Enhancement of epidermal regeneration by biosynthetic epidermal growth factor. J Exp Med 1986; 163: 1319-1324
  • 18 Hong JP, Jung HD, Kim YW. Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers. Ann Plast Surg 2006; 56: 394-398
  • 19 Choi J, Moon SY, Hong JP. et al. Epidermal growth factor induces cell death in the absence of overexpressed epidermal growth factor receptor and ErbB2 in various human cancer cell lines. Cancer Invest 2010; 28: 505-514